Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinzelmann

Showing results (601-610 of 663) with videos related to

Pageof 67
Sort By:
The European Respiratory Journal|May 23, 2022
Single-cell RNA sequencing identifies G-protein coupled receptor 87 as a basal cell marker expressed in distal honeycomb cysts in idiopathic pulmonary fibrosisKatharina Heinzelmann, Qianjiang Hu, Yan Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2021
Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)Nicolaus Kröger, Katja Sockel, Christine Wolschke, et al.
Circulation|May 8, 2015
Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac TroponinKarin Wildi, Maria Rubini Gimenez, Raphael Twerenbold, et al.
Cancers|April 14, 2026
Long-Term Young Adult Cancer Survivors with Ovarian Cancer: Subgroup Analysis of the Study "Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer": The International NOGGO, ENGOT, and GCIG SurveyDesislava Dimitrova, Eleftherios Pierre Samartzis, Dario Zocholl, et al.
JAMA Network Open|November 5, 2025
PARP Inhibitor Maintenance After First-Line Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: A Systematic Review and Meta-AnalysisStamatios Petousis, Ilker Kahramanoglu, Christian Appenzeller-Herzog, et al.
Cell Reports. Medicine|December 31, 2025
zAvatar-test-A functional precision model to personalize ovarian cancer treatments: Results from a co-clinical studyMarta F Estrada, Filipa Amorim, Filipa Ferreira da Silva, et al.
Gynecologic Oncology|July 19, 2022
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trialDana M Chase, Margarita Romeo Marín, Floor Backes, et al.
International Journal of Molecular Sciences|November 27, 2024
Insights into the Identification of iPSC- and Monocyte-Derived Macrophage-Polarizing Compounds by AI-Fueled Cell Painting Analysis ToolsJohanna B Brüggenthies, Jakob Dittmer, Eva Martin, et al.
Oncoimmunology|August 21, 2019
CCR5 status and metastatic progression in colorectal cancerMeggy Suarez-Carmona, Pornpimol Chaorentong, Jakob Nikolas Kather, et al.
Journal for Immunotherapy of Cancer|November 1, 2022
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumorsMarina Natoli, Klas Hatje, Pratiksha Gulati, et al.
Pageof 67

Showing results (601-610 of 663) with videos related to

Sort By:
Pageof 67
The European Respiratory Journal|May 23, 2022
Single-cell RNA sequencing identifies G-protein coupled receptor 87 as a basal cell marker expressed in distal honeycomb cysts in idiopathic pulmonary fibrosisKatharina Heinzelmann, Qianjiang Hu, Yan Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2021
Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)Nicolaus Kröger, Katja Sockel, Christine Wolschke, et al.
Circulation|May 8, 2015
Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac TroponinKarin Wildi, Maria Rubini Gimenez, Raphael Twerenbold, et al.
Cancers|April 14, 2026
Long-Term Young Adult Cancer Survivors with Ovarian Cancer: Subgroup Analysis of the Study "Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer": The International NOGGO, ENGOT, and GCIG SurveyDesislava Dimitrova, Eleftherios Pierre Samartzis, Dario Zocholl, et al.
JAMA Network Open|November 5, 2025
PARP Inhibitor Maintenance After First-Line Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: A Systematic Review and Meta-AnalysisStamatios Petousis, Ilker Kahramanoglu, Christian Appenzeller-Herzog, et al.
Cell Reports. Medicine|December 31, 2025
zAvatar-test-A functional precision model to personalize ovarian cancer treatments: Results from a co-clinical studyMarta F Estrada, Filipa Amorim, Filipa Ferreira da Silva, et al.
Gynecologic Oncology|July 19, 2022
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trialDana M Chase, Margarita Romeo Marín, Floor Backes, et al.
International Journal of Molecular Sciences|November 27, 2024
Insights into the Identification of iPSC- and Monocyte-Derived Macrophage-Polarizing Compounds by AI-Fueled Cell Painting Analysis ToolsJohanna B Brüggenthies, Jakob Dittmer, Eva Martin, et al.
Oncoimmunology|August 21, 2019
CCR5 status and metastatic progression in colorectal cancerMeggy Suarez-Carmona, Pornpimol Chaorentong, Jakob Nikolas Kather, et al.
Journal for Immunotherapy of Cancer|November 1, 2022
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumorsMarina Natoli, Klas Hatje, Pratiksha Gulati, et al.
Pageof 67